Depression, HIV
Conditions
Keywords
HIV related adverse events, immunological failure, virological failure, quality of life, depression, genotypic resistance
Brief summary
The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.
Detailed description
This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.
Interventions
DRUGstandard regimens according to the Thai Ministry of Public Health national guidelines
Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
Sponsors
Bamrasnaradura Infectious Diseases Institute
Sanpatong Hospital
The HIV Netherlands Australia Thailand Research Collaboration
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens 2. Signed consent form 3. Age\> 18 years
Exclusion criteria
1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room. 2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of. 3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data. 4. Patients who have been diagnosed by a medical condition that Alcoholism
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HIV related adverse events | 1 year | Time until patient has HIV related adverse events |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immunological failure | 1 year | time to immunological failure |
| virological failure | 1 year | time to virological failure |
| the change of quality of life | 1 year | time to change of quality of life |
| depression | 1 year | time when patient develops depression |
| genotypic resistance | 1 year | time to developing genotypic resistance |
Countries
Thailand
Outcome results
None listed